News
22h
Medpage Today on MSNEfruxifermin Did Not Reduce Fibrosis in MASH-Related Compensated CirrhosisUse of the investigational drug efruxifermin did not significantly reduce fibrosis in patients with compensated cirrhosis ...
Despite Ozempic being the most recognisable brand name, as far as the people prescribing it are concerned weight loss is ...
Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed ...
Lars Fruergaard Jørgensen, the boss of Danish pharmaceutical giant Novo Nordisk, explained what impact the drugs can have on users weight in the long run ...
We recently published an article titled These 10 Stocks Moved the Market This Week, Here’s Why. In this article, we are going ...
Nordics for Climate Action, a collaborative initiative of the consulates general of Denmark, Finland, and Norway in Shanghai, ...
Producing nuclear energy on Danish soil was out of the question for decades. But with Russian aggression and a climate crisis ...
Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results